Fasting Whole-Body Energy Homeostasis and Hepatic Energy Metabolism in Nondiabetic Humans with Fatty Liver

Table 1

Biochemistry and clinical features of individuals with newly diagnosed fatty liver and controls.

	Fatty liver	Controls	value
Number and sex (F/M)	22 (2/20)	22 (2/20)
Age (years)
BMI (kg/m^2)
Total cholesterol (mg/dl)			0.37
HDL cholesterol (mg/dl)			0.07
Triglycerides (mg/dl)			0.01
NEFA (mg/dl)			0.91
Creatinine (mg/dl)			0.29
Plasma glucose (mg/dl)			0.62
Plasma insulin (μU/ml)			0.06
Plasma C-peptide (ng/ml)			0.01
HOMA2-B (%)			0.46
HOMA2-S (%)			0.05
IHF content (% wet weight)			0.0001
	Range: 5.40–39.25	Range: 0.84–4.28

; independent-samples -test (2-tailed). HOMA: HOMA2: homeostatic model assessment; HOMA2-S: insulin sensitivity; HOMA2-B: β-cell sensitivity.